BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22491899)

  • 1. Nipah and hendra virus interactions with the innate immune system.
    Basler CF
    Curr Top Microbiol Immunol; 2012; 359():123-52. PubMed ID: 22491899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions.
    Glennon NB; Jabado O; Lo MK; Shaw ML
    J Virol; 2015 Aug; 89(15):7550-66. PubMed ID: 25972557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nipah and Hendra Virus Nucleoproteins Inhibit Nuclear Accumulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT2 by Interfering with Their Complex Formation.
    Sugai A; Sato H; Takayama I; Yoneda M; Kai C
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Matrix Protein of Nipah Virus Targets the E3-Ubiquitin Ligase TRIM6 to Inhibit the IKKε Kinase-Mediated Type-I IFN Antiviral Response.
    Bharaj P; Wang YE; Dawes BE; Yun TE; Park A; Yen B; Basler CF; Freiberg AN; Lee B; Rajsbaum R
    PLoS Pathog; 2016 Sep; 12(9):e1005880. PubMed ID: 27622505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hendra and Nipah viruses: why are they so deadly?
    Marsh GA; Wang LF
    Curr Opin Virol; 2012 Jun; 2(3):242-7. PubMed ID: 22483665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hendra and Nipah viruses: different and dangerous.
    Eaton BT; Broder CC; Middleton D; Wang LF
    Nat Rev Microbiol; 2006 Jan; 4(1):23-35. PubMed ID: 16357858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate-dependent enhancement of henipavirus infection.
    Mathieu C; Dhondt KP; Châlons M; Mély S; Raoul H; Negre D; Cosset FL; Gerlier D; Vivès RR; Horvat B
    mBio; 2015 Mar; 6(2):e02427. PubMed ID: 25759505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization strategies against henipaviruses.
    Broder CC; Geisbert TW; Xu K; Nikolov DB; Wang LF; Middleton D; Pallister J; Bossart KN
    Curr Top Microbiol Immunol; 2012; 359():197-223. PubMed ID: 22481140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Intrinsically Disordered W Protein Is Multifunctional during Henipavirus Infection, Disrupting Host Signalling Pathways and Nuclear Import.
    Tsimbalyuk S; Cross EM; Hoad M; Donnelly CM; Roby JA; Forwood JK
    Cells; 2020 Aug; 9(8):. PubMed ID: 32824665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response.
    Lo MK; Peeples ME; Bellini WJ; Nichol ST; Rota PA; Spiropoulou CF
    PLoS One; 2012; 7(10):e47790. PubMed ID: 23094089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hendra and Nipah viruses: pathogenesis and therapeutics.
    Eaton BT; Broder CC; Wang LF
    Curr Mol Med; 2005 Dec; 5(8):805-16. PubMed ID: 16375714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-pathogenic Henipavirus Cedar paramyxovirus phosphoprotein has a compromised ability to target STAT1 and STAT2.
    Lieu KG; Marsh GA; Wang LF; Netter HJ
    Antiviral Res; 2015 Dec; 124():69-76. PubMed ID: 26526590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of the Nipah Virus P, V, and W Proteins across the STAT Family of Transcription Factors.
    Keiffer TR; Ciancanelli MJ; Edwards MR; Basler CF
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33328346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
    Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
    J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Henipavirus pathogenesis and antiviral approaches.
    Mathieu C; Horvat B
    Expert Rev Anti Infect Ther; 2015 Mar; 13(3):343-54. PubMed ID: 25634624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developments towards effective treatments for Nipah and Hendra virus infection.
    Bossart KN; Broder CC
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling.
    Rodriguez JJ; Horvath CM
    Viral Immunol; 2004; 17(2):210-9. PubMed ID: 15279700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of Hendra and Nipah virus infection in humans.
    Escaffre O; Borisevich V; Rockx B
    J Infect Dev Ctries; 2013 Apr; 7(4):308-11. PubMed ID: 23592639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells.
    Feagins AR; Basler CF
    Virology; 2015 Nov; 485():145-52. PubMed ID: 26255028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferon signaling protects mice from lethal henipavirus infection.
    Dhondt KP; Mathieu C; Chalons M; Reynaud JM; Vallve A; Raoul H; Horvat B
    J Infect Dis; 2013 Jan; 207(1):142-51. PubMed ID: 23089589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.